| Product NDC: | 53808-0205 |
| Proprietary Name: | Asacol |
| Non Proprietary Name: | mesalamine |
| Active Ingredient(s): | 400 mg/1 & nbsp; mesalamine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53808-0205 |
| Labeler Name: | State of Florida DOH Central Pharmacy |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019651 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090701 |
| Package NDC: | 53808-0205-1 |
| Package Description: | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (53808-0205-1) |
| NDC Code | 53808-0205-1 |
| Proprietary Name | Asacol |
| Package Description | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (53808-0205-1) |
| Product NDC | 53808-0205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mesalamine |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | NDA |
| Labeler Name | State of Florida DOH Central Pharmacy |
| Substance Name | MESALAMINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |